 | • レポートコード：MRC2-11QY05451 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はドライアイ症候群のグローバル市場について調査・分析したレポートです。種類別（処方薬、店頭（OTC）薬）市場規模、用途別（病院・診療所、臨床検査室、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ドライアイ症候群の競争状況、市場シェア ・世界のドライアイ症候群市場：種類別市場規模 2015年-2020年（処方薬、店頭（OTC）薬） ・世界のドライアイ症候群市場：種類別市場規模予測 2021年-2026年（処方薬、店頭（OTC）薬） ・世界のドライアイ症候群市場：用途別市場規模 2015年-2020年（病院・診療所、臨床検査室、その他） ・世界のドライアイ症候群市場：用途別市場規模予測 2021年-2026年（病院・診療所、臨床検査室、その他） ・北米のドライアイ症候群市場分析：米国、カナダ ・ヨーロッパのドライアイ症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのドライアイ症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のドライアイ症候群市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのドライアイ症候群市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Novartis、Otsuka Holdings、Santen Pharmaceutical、Aerie Pharmaceutical、Akorn、Bausch & Lomb、Johnson & Johnson、Merck、MIMETOGEN、ReGenTree、Sun Pharmaceutical、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
Dry eye syndrome is gaining prominence due to the changing lifestyles, consumption of specified medicines, and increased rate of diseases. Autoimmune diseases, genetic factors, environmental conditions, and routine practices such as extended usage of contact lenses and prolonged computer usage also cause dry eye syndrome.
Market Analysis and Insights: Global Dry Eye Syndrome Market
The global Dry Eye Syndrome market size is projected to reach US$ 3104.9 million by 2026, from US$ 2928 million in 2020, at a CAGR of 5.6%% during 2021-2026.
Global Dry Eye Syndrome Scope and Market Size
Dry Eye Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dry Eye Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dry Eye Syndrome market is segmented into
Prescription drugs
Over-the-counter (OTC) drugs
Segment by Application, the Dry Eye Syndrome market is segmented into
Hospitals and Clinics
Medical Laboratories
Others
Regional and Country-level Analysis
The Dry Eye Syndrome market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dry Eye Syndrome market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dry Eye Syndrome Market Share Analysis
Dry Eye Syndrome market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dry Eye Syndrome business, the date to enter into the Dry Eye Syndrome market, Dry Eye Syndrome product introduction, recent developments, etc.
The major vendors covered:
Allergan
Novartis
Otsuka Holdings
Santen Pharmaceutical
Aerie Pharmaceutical
Akorn
Bausch & Lomb
Johnson & Johnson
Merck
MIMETOGEN
ReGenTree
Sun Pharmaceutical
Teva Pharmaceutical
1 Study Coverage
1.1 Dry Eye Syndrome Product Introduction
1.2 Market Segments
1.3 Key Dry Eye Syndrome Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dry Eye Syndrome Market Size Growth Rate by Type
1.4.2 Prescription drugs
1.4.3 Over-the-counter (OTC) drugs
1.5 Market by Application
1.5.1 Global Dry Eye Syndrome Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Medical Laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dry Eye Syndrome Market Size, Estimates and Forecasts
2.1.1 Global Dry Eye Syndrome Revenue 2015-2026
2.1.2 Global Dry Eye Syndrome Sales 2015-2026
2.2 Global Dry Eye Syndrome, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dry Eye Syndrome Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dry Eye Syndrome Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dry Eye Syndrome Competitor Landscape by Players
3.1 Dry Eye Syndrome Sales by Manufacturers
3.1.1 Dry Eye Syndrome Sales by Manufacturers (2015-2020)
3.1.2 Dry Eye Syndrome Sales Market Share by Manufacturers (2015-2020)
3.2 Dry Eye Syndrome Revenue by Manufacturers
3.2.1 Dry Eye Syndrome Revenue by Manufacturers (2015-2020)
3.2.2 Dry Eye Syndrome Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dry Eye Syndrome Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Revenue in 2019
3.2.5 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dry Eye Syndrome Price by Manufacturers
3.4 Dry Eye Syndrome Manufacturing Base Distribution, Product Types
3.4.1 Dry Eye Syndrome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dry Eye Syndrome Product Type
3.4.3 Date of International Manufacturers Enter into Dry Eye Syndrome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dry Eye Syndrome Market Size by Type (2015-2020)
4.1.1 Global Dry Eye Syndrome Sales by Type (2015-2020)
4.1.2 Global Dry Eye Syndrome Revenue by Type (2015-2020)
4.1.3 Dry Eye Syndrome Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dry Eye Syndrome Market Size Forecast by Type (2021-2026)
4.2.1 Global Dry Eye Syndrome Sales Forecast by Type (2021-2026)
4.2.2 Global Dry Eye Syndrome Revenue Forecast by Type (2021-2026)
4.2.3 Dry Eye Syndrome Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dry Eye Syndrome Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dry Eye Syndrome Market Size by Application (2015-2020)
5.1.1 Global Dry Eye Syndrome Sales by Application (2015-2020)
5.1.2 Global Dry Eye Syndrome Revenue by Application (2015-2020)
5.1.3 Dry Eye Syndrome Price by Application (2015-2020)
5.2 Dry Eye Syndrome Market Size Forecast by Application (2021-2026)
5.2.1 Global Dry Eye Syndrome Sales Forecast by Application (2021-2026)
5.2.2 Global Dry Eye Syndrome Revenue Forecast by Application (2021-2026)
5.2.3 Global Dry Eye Syndrome Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dry Eye Syndrome by Country
6.1.1 North America Dry Eye Syndrome Sales by Country
6.1.2 North America Dry Eye Syndrome Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dry Eye Syndrome Market Facts & Figures by Type
6.3 North America Dry Eye Syndrome Market Facts & Figures by Application
7 Europe
7.1 Europe Dry Eye Syndrome by Country
7.1.1 Europe Dry Eye Syndrome Sales by Country
7.1.2 Europe Dry Eye Syndrome Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dry Eye Syndrome Market Facts & Figures by Type
7.3 Europe Dry Eye Syndrome Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dry Eye Syndrome by Region
8.1.1 Asia Pacific Dry Eye Syndrome Sales by Region
8.1.2 Asia Pacific Dry Eye Syndrome Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Type
8.3 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dry Eye Syndrome by Country
9.1.1 Latin America Dry Eye Syndrome Sales by Country
9.1.2 Latin America Dry Eye Syndrome Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dry Eye Syndrome Market Facts & Figures by Type
9.3 Central & South America Dry Eye Syndrome Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dry Eye Syndrome by Country
10.1.1 Middle East and Africa Dry Eye Syndrome Sales by Country
10.1.2 Middle East and Africa Dry Eye Syndrome Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Type
10.3 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Dry Eye Syndrome Products Offered
11.1.5 Allergan Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Dry Eye Syndrome Products Offered
11.2.5 Novartis Related Developments
11.3 Otsuka Holdings
11.3.1 Otsuka Holdings Corporation Information
11.3.2 Otsuka Holdings Description and Business Overview
11.3.3 Otsuka Holdings Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Otsuka Holdings Dry Eye Syndrome Products Offered
11.3.5 Otsuka Holdings Related Developments
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Corporation Information
11.4.2 Santen Pharmaceutical Description and Business Overview
11.4.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Santen Pharmaceutical Dry Eye Syndrome Products Offered
11.4.5 Santen Pharmaceutical Related Developments
11.5 Aerie Pharmaceutical
11.5.1 Aerie Pharmaceutical Corporation Information
11.5.2 Aerie Pharmaceutical Description and Business Overview
11.5.3 Aerie Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aerie Pharmaceutical Dry Eye Syndrome Products Offered
11.5.5 Aerie Pharmaceutical Related Developments
11.6 Akorn
11.6.1 Akorn Corporation Information
11.6.2 Akorn Description and Business Overview
11.6.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Akorn Dry Eye Syndrome Products Offered
11.6.5 Akorn Related Developments
11.7 Bausch & Lomb
11.7.1 Bausch & Lomb Corporation Information
11.7.2 Bausch & Lomb Description and Business Overview
11.7.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bausch & Lomb Dry Eye Syndrome Products Offered
11.7.5 Bausch & Lomb Related Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Description and Business Overview
11.8.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Johnson & Johnson Dry Eye Syndrome Products Offered
11.8.5 Johnson & Johnson Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Dry Eye Syndrome Products Offered
11.9.5 Merck Related Developments
11.10 MIMETOGEN
11.10.1 MIMETOGEN Corporation Information
11.10.2 MIMETOGEN Description and Business Overview
11.10.3 MIMETOGEN Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MIMETOGEN Dry Eye Syndrome Products Offered
11.10.5 MIMETOGEN Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Dry Eye Syndrome Products Offered
11.1.5 Allergan Related Developments
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Corporation Information
11.12.2 Sun Pharmaceutical Description and Business Overview
11.12.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sun Pharmaceutical Products Offered
11.12.5 Sun Pharmaceutical Related Developments
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Corporation Information
11.13.2 Teva Pharmaceutical Description and Business Overview
11.13.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Pharmaceutical Products Offered
11.13.5 Teva Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dry Eye Syndrome Market Estimates and Projections by Region
12.1.1 Global Dry Eye Syndrome Sales Forecast by Regions 2021-2026
12.1.2 Global Dry Eye Syndrome Revenue Forecast by Regions 2021-2026
12.2 North America Dry Eye Syndrome Market Size Forecast (2021-2026)
12.2.1 North America: Dry Eye Syndrome Sales Forecast (2021-2026)
12.2.2 North America: Dry Eye Syndrome Revenue Forecast (2021-2026)
12.2.3 North America: Dry Eye Syndrome Market Size Forecast by Country (2021-2026)
12.3 Europe Dry Eye Syndrome Market Size Forecast (2021-2026)
12.3.1 Europe: Dry Eye Syndrome Sales Forecast (2021-2026)
12.3.2 Europe: Dry Eye Syndrome Revenue Forecast (2021-2026)
12.3.3 Europe: Dry Eye Syndrome Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dry Eye Syndrome Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dry Eye Syndrome Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dry Eye Syndrome Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dry Eye Syndrome Market Size Forecast by Region (2021-2026)
12.5 Latin America Dry Eye Syndrome Market Size Forecast (2021-2026)
12.5.1 Latin America: Dry Eye Syndrome Sales Forecast (2021-2026)
12.5.2 Latin America: Dry Eye Syndrome Revenue Forecast (2021-2026)
12.5.3 Latin America: Dry Eye Syndrome Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dry Eye Syndrome Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dry Eye Syndrome Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dry Eye Syndrome Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dry Eye Syndrome Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dry Eye Syndrome Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dry Eye Syndrome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dry Eye Syndrome Market Segments
Table 2. Ranking of Global Top Dry Eye Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dry Eye Syndrome Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription drugs
Table 5. Major Manufacturers of Over-the-counter (OTC) drugs
Table 6. Global Dry Eye Syndrome Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Dry Eye Syndrome Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Dry Eye Syndrome Sales by Regions 2015-2020 (K Units)
Table 9. Global Dry Eye Syndrome Sales Market Share by Regions (2015-2020)
Table 10. Global Dry Eye Syndrome Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Dry Eye Syndrome Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Dry Eye Syndrome Sales Share by Manufacturers (2015-2020)
Table 13. Global Dry Eye Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome as of 2019)
Table 15. Dry Eye Syndrome Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Dry Eye Syndrome Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Dry Eye Syndrome Price (2015-2020) (USD/Unit)
Table 18. Dry Eye Syndrome Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Dry Eye Syndrome Product Type
Table 20. Date of International Manufacturers Enter into Dry Eye Syndrome Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 23. Global Dry Eye Syndrome Sales Share by Type (2015-2020)
Table 24. Global Dry Eye Syndrome Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Dry Eye Syndrome Revenue Share by Type (2015-2020)
Table 26. Dry Eye Syndrome Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 28. Global Dry Eye Syndrome Sales Share by Application (2015-2020)
Table 29. North America Dry Eye Syndrome Sales by Country (2015-2020) (K Units)
Table 30. North America Dry Eye Syndrome Sales Market Share by Country (2015-2020)
Table 31. North America Dry Eye Syndrome Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Dry Eye Syndrome Revenue Market Share by Country (2015-2020)
Table 33. North America Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 34. North America Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Table 35. North America Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 36. North America Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Table 37. Europe Dry Eye Syndrome Sales by Country (2015-2020) (K Units)
Table 38. Europe Dry Eye Syndrome Sales Market Share by Country (2015-2020)
Table 39. Europe Dry Eye Syndrome Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Dry Eye Syndrome Revenue Market Share by Country (2015-2020)
Table 41. Europe Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 42. Europe Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Table 43. Europe Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 44. Europe Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Dry Eye Syndrome Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Dry Eye Syndrome Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Dry Eye Syndrome Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Table 53. Latin America Dry Eye Syndrome Sales by Country (2015-2020) (K Units)
Table 54. Latin America Dry Eye Syndrome Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Dry Eye Syndrome Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Dry Eye Syndrome Revenue Market Share by Country (2015-2020)
Table 57. Latin America Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 58. Latin America Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Table 59. Latin America Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 60. Latin America Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Dry Eye Syndrome Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Dry Eye Syndrome Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Dry Eye Syndrome Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Dry Eye Syndrome Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Dry Eye Syndrome Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Dry Eye Syndrome Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Table 69. Allergan Corporation Information
Table 70. Allergan Description and Major Businesses
Table 71. Allergan Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Allergan Product
Table 73. Allergan Recent Development
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. Otsuka Holdings Corporation Information
Table 80. Otsuka Holdings Description and Major Businesses
Table 81. Otsuka Holdings Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Otsuka Holdings Product
Table 83. Otsuka Holdings Recent Development
Table 84. Santen Pharmaceutical Corporation Information
Table 85. Santen Pharmaceutical Description and Major Businesses
Table 86. Santen Pharmaceutical Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Santen Pharmaceutical Product
Table 88. Santen Pharmaceutical Recent Development
Table 89. Aerie Pharmaceutical Corporation Information
Table 90. Aerie Pharmaceutical Description and Major Businesses
Table 91. Aerie Pharmaceutical Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Aerie Pharmaceutical Product
Table 93. Aerie Pharmaceutical Recent Development
Table 94. Akorn Corporation Information
Table 95. Akorn Description and Major Businesses
Table 96. Akorn Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Akorn Product
Table 98. Akorn Recent Development
Table 99. Bausch & Lomb Corporation Information
Table 100. Bausch & Lomb Description and Major Businesses
Table 101. Bausch & Lomb Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Bausch & Lomb Product
Table 103. Bausch & Lomb Recent Development
Table 104. Johnson & Johnson Corporation Information
Table 105. Johnson & Johnson Description and Major Businesses
Table 106. Johnson & Johnson Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. MIMETOGEN Corporation Information
Table 115. MIMETOGEN Description and Major Businesses
Table 116. MIMETOGEN Dry Eye Syndrome Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. MIMETOGEN Product
Table 118. MIMETOGEN Recent Development
Table 119. ReGenTree Corporation Information
Table 120. ReGenTree Description and Major Businesses
Table 121. ReGenTree Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. ReGenTree Product
Table 123. ReGenTree Recent Development
Table 124. Sun Pharmaceutical Corporation Information
Table 125. Sun Pharmaceutical Description and Major Businesses
Table 126. Sun Pharmaceutical Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Sun Pharmaceutical Product
Table 128. Sun Pharmaceutical Recent Development
Table 129. Teva Pharmaceutical Corporation Information
Table 130. Teva Pharmaceutical Description and Major Businesses
Table 131. Teva Pharmaceutical Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Teva Pharmaceutical Product
Table 133. Teva Pharmaceutical Recent Development
Table 134. Global Dry Eye Syndrome Sales Forecast by Regions (2021-2026) (K Units)
Table 135. Global Dry Eye Syndrome Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Dry Eye Syndrome Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Dry Eye Syndrome Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Dry Eye Syndrome Sales Forecast by Country (2021-2026) (K Units)
Table 139. North America: Dry Eye Syndrome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Dry Eye Syndrome Sales Forecast by Country (2021-2026) (K Units)
Table 141. Europe: Dry Eye Syndrome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Dry Eye Syndrome Sales Forecast by Region (2021-2026) (K Units)
Table 143. Asia Pacific: Dry Eye Syndrome Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Dry Eye Syndrome Sales Forecast by Country (2021-2026) (K Units)
Table 145. Latin America: Dry Eye Syndrome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Dry Eye Syndrome Sales Forecast by Country (2021-2026) (K Units)
Table 147. Middle East and Africa: Dry Eye Syndrome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Dry Eye Syndrome Players
Table 152. Dry Eye Syndrome Customers List
Table 153. Dry Eye Syndrome Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Syndrome Product Picture
Figure 2. Global Dry Eye Syndrome Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription drugs Product Picture
Figure 4. Over-the-counter (OTC) drugs Product Picture
Figure 5. Global Dry Eye Syndrome Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals and Clinics
Figure 7. Medical Laboratories
Figure 8. Others
Figure 9. Dry Eye Syndrome Report Years Considered
Figure 10. Global Dry Eye Syndrome Market Size 2015-2026 (US$ Million)
Figure 11. Global Dry Eye Syndrome Sales 2015-2026 (K Units)
Figure 12. Global Dry Eye Syndrome Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dry Eye Syndrome Sales Market Share by Region (2015-2020)
Figure 14. Global Dry Eye Syndrome Sales Market Share by Region in 2019
Figure 15. Global Dry Eye Syndrome Revenue Market Share by Region (2015-2020)
Figure 16. Global Dry Eye Syndrome Revenue Market Share by Region in 2019
Figure 17. Global Dry Eye Syndrome Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Revenue in 2019
Figure 19. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dry Eye Syndrome Sales Market Share by Type (2015-2020)
Figure 21. Global Dry Eye Syndrome Sales Market Share by Type in 2019
Figure 22. Global Dry Eye Syndrome Revenue Market Share by Type (2015-2020)
Figure 23. Global Dry Eye Syndrome Revenue Market Share by Type in 2019
Figure 24. Global Dry Eye Syndrome Market Share by Price Range (2015-2020)
Figure 25. Global Dry Eye Syndrome Sales Market Share by Application (2015-2020)
Figure 26. Global Dry Eye Syndrome Sales Market Share by Application in 2019
Figure 27. Global Dry Eye Syndrome Revenue Market Share by Application (2015-2020)
Figure 28. Global Dry Eye Syndrome Revenue Market Share by Application in 2019
Figure 29. North America Dry Eye Syndrome Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Dry Eye Syndrome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Dry Eye Syndrome Sales Market Share by Country in 2019
Figure 32. North America Dry Eye Syndrome Revenue Market Share by Country in 2019
Figure 33. U.S. Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Dry Eye Syndrome Market Share by Type in 2019
Figure 38. North America Dry Eye Syndrome Market Share by Application in 2019
Figure 39. Europe Dry Eye Syndrome Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Dry Eye Syndrome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Dry Eye Syndrome Sales Market Share by Country in 2019
Figure 42. Europe Dry Eye Syndrome Revenue Market Share by Country in 2019
Figure 43. Germany Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Dry Eye Syndrome Market Share by Type in 2019
Figure 54. Europe Dry Eye Syndrome Market Share by Application in 2019
Figure 55. Asia Pacific Dry Eye Syndrome Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Dry Eye Syndrome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Dry Eye Syndrome Sales Market Share by Region in 2019
Figure 58. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region in 2019
Figure 59. China Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Dry Eye Syndrome Market Share by Type in 2019
Figure 82. Asia Pacific Dry Eye Syndrome Market Share by Application in 2019
Figure 83. Latin America Dry Eye Syndrome Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Dry Eye Syndrome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Dry Eye Syndrome Sales Market Share by Country in 2019
Figure 86. Latin America Dry Eye Syndrome Revenue Market Share by Country in 2019
Figure 87. Mexico Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Dry Eye Syndrome Market Share by Type in 2019
Figure 94. Latin America Dry Eye Syndrome Market Share by Application in 2019
Figure 95. Middle East and Africa Dry Eye Syndrome Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Dry Eye Syndrome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Dry Eye Syndrome Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Dry Eye Syndrome Revenue Market Share by Country in 2019
Figure 99. Turkey Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Dry Eye Syndrome Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Dry Eye Syndrome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Dry Eye Syndrome Market Share by Type in 2019
Figure 106. Middle East and Africa Dry Eye Syndrome Market Share by Application in 2019
Figure 107. North America Dry Eye Syndrome Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Dry Eye Syndrome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Dry Eye Syndrome Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Dry Eye Syndrome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Dry Eye Syndrome Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Dry Eye Syndrome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Dry Eye Syndrome Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Dry Eye Syndrome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Dry Eye Syndrome Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Dry Eye Syndrome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…- アスペルガー症候群治療薬の世界市場（～2026年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
- セロトニン症候群の世界市場（～2026年） Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. US accou…
- ギランバレー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Guillain-Barre Syndrome Drugs Market The global Guillain-Barre Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Guillain-Barre Syndrome Drugs Scope and Market Size Gui…
- 短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…